powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1952842379
Elizabeth Pan
Hematology-Oncology
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
90.7
Quality
94.0
Cost
65.1
Improvement activities
40.0
Promoting interop.
92.0
Payment adjustment
0.66%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
533
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
12
Brand share
34.0%
Top prescribed drugs
Abiraterone Acetate
137 claims
Prednisone
130 claims
Relugolix
67 claims
Darolutamide
56 claims
Enzalutamide
44 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
529
Unique beneficiaries
—
Total services
1,517
Distinct HCPCS
7
Medicare payment
$97K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — above median (cohort median 4,173).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.